Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 182

1.

Platelet activation triggered by Chlamydia pneumoniae is antagonized by 12-lipoxygenase inhibitors but not cyclooxygenase inhibitors.

Kälvegren H, Andersson J, Grenegård M, Bengtsson T.

Eur J Pharmacol. 2007 Jul 2;566(1-3):20-7. Epub 2007 Mar 24.

PMID:
17459368
2.

Endothelial cells play an important role in the antiaggregatory effect of nitric oxide.

Klinge JM, Topf HG, Trusen B, Rauh M, Rascher W, Dötsch J.

Crit Care Med. 2003 Jul;31(7):2010-4.

PMID:
12847397
3.

Augmentation of U46619 induced human platelet aggregation by aspirin.

Kim JM, Koo YK, Jin J, Lee YY, Park S, Yun-Choi HS.

Platelets. 2009 Mar;20(2):111-9. doi: 10.1080/09537100802632282.

PMID:
19235053
4.

Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation.

Rotondo S, Krauze-Brzósko K, Manarini S, Evangelista V, Cerletti C.

Eur J Pharmacol. 2004 Mar 19;488(1-3):79-83.

PMID:
15044038
5.
6.

Toll-like receptor 2 stimulation of platelets is mediated by purinergic P2X1-dependent Ca2+ mobilisation, cyclooxygenase and purinergic P2Y1 and P2Y12 receptor activation.

Kälvegren H, Skoglund C, Helldahl C, Lerm M, Grenegård M, Bengtsson T.

Thromb Haemost. 2010 Feb;103(2):398-407. doi: 10.1160/TH09-07-0442. Epub 2009 Dec 18.

PMID:
20024498
8.

Enhanced platelet aggregation and activation under conditions of hypothermia.

Xavier RG, White AE, Fox SC, Wilcox RG, Heptinstall S.

Thromb Haemost. 2007 Dec;98(6):1266-75.

PMID:
18064324
9.
10.
11.
12.

Chlamydia pneumoniae binds to platelets and triggers P-selectin expression and aggregation: a causal role in cardiovascular disease?

Kälvegren H, Majeed M, Bengtsson T.

Arterioscler Thromb Vasc Biol. 2003 Sep 1;23(9):1677-83. Epub 2003 Jul 3.

13.
14.
15.
16.

Pharmacological profiles of cloned mammalian P2Y-receptor subtypes.

von Kügelgen I.

Pharmacol Ther. 2006 Jun;110(3):415-32. Epub 2005 Oct 28. Review.

PMID:
16257449
17.

Antiplatelet activity of caffeic acid phenethyl ester is mediated through a cyclic GMP-dependent pathway in human platelets.

Chen TG, Lee JJ, Lin KH, Shen CH, Chou DS, Sheu JR.

Chin J Physiol. 2007 Jun 30;50(3):121-6.

PMID:
17867432
18.

Signal transduction system in epinephrine stimulated platelets; comparison between epinephrine sensitive and insensitive platelets.

Nakamura T, Ariyoshi H, Kambayashi J, Ikeda M, Shinoki N, Kawasaki T, Monden M.

Thromb Res. 1997 Jan 15;85(2):83-93.

PMID:
9058482
19.

Effects on primary haemostasis of an anti-inflammatory agent with 5-lipoxygenase and cyclooxygenase inhibitory activity.

Hernandez MR, Tonda R, Pedreño J, Salas E, Arderiu G, Pino M, Serradell M, Escolar G.

J Cardiovasc Med (Hagerstown). 2006 Dec;7(12):859-65.

PMID:
17122671
20.

Antitumor effects of lipoxygenase inhibitors on murine bladder cancer cell line (MBT-2).

Ikemoto S, Sugimura K, Kuratukuri K, Nakatani T.

Anticancer Res. 2004 Mar-Apr;24(2B):733-6.

Supplemental Content

Support Center